Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Soluble guanylate cyclase activators for treating portal hypertension

Soluble guanylate cyclase activators for treating portal hypertension

US Patent 12226411 · Granted Feb 18, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical composition, methods for treating and uses thereof2024
Alkoxy pyrazoles as soluble guanylate cyclase activators2023
Alkoxy pyrazoles as soluble guanylate cyclase activators2023
Pharmaceutical composition, methods for treating and uses thereof2019
Synthetic double-stranded oligonucleotides for specific inhibition of gene expre2014
Pyrazolopyridine derivatives as inhibitors of β-Adrenergic receptor kinase 12011
Oligoribonucleotide derivatives for specific inhibition of gene expression2009
Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropa2009
High-throughput-assay with high sensitivity for measuring of the activity of β-a2007
Use of EDG2 receptor in an animal model of heart failure2007
Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropa2005
Method for the determination of homocysteine2002